ArticleJournal of experimental & clinical cancer research : CR2019

Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer.

Yuning Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.